UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
For beginners, compare index funds and mutual funds on cost, simplicity, and diversification to choose the easier path to investing.
24,324 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
April data show a split in new construction: multifamily projects surged while single-family starts declined, leaving...
Wall Street’s bearish take on Plug Power stock has critics unsure. This article builds a practical bull case, showing...
Looking to build retirement wealth with a focus on AI? This guide highlights three AI stocks worth holding until reti...
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Texas Instruments is outperforming NVIDIA in 2026 as the chip landscape shifts from GPU hype to broad AI infrastructu...
In May, centrus energy stock sank after a positive start to the quarter. This article breaks down the core forces beh...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...
Oracle beat on earnings and grew its contract backlog to a record level, yet investors pounced on higher AI costs, se...
When a high-profile custody ruling grants one parent primary physical custody, families must rethink daily budgeting,...
Investors are buzzing about Avalanche. Could avalanche about have biggest spark this year? Here’s how the platform wo...
A fresh market thesis points to a higher Oracle share price by 2027, anchored in AI-driven cloud growth and a swellin...